Phone:
+1 877 302 8632
Fax:
+1 888 205 9894 (Toll-free)
E-Mail:
orders@antibodies-online.com

Recombinant CD70 (Vorsetuzumab Biosimilar) antibody

Research Grade Reactivity: Human Host: Humanized Chimeric unconjugated Recombinant Antibody
Catalog No. ABIN7598103
  • Target See all CD70 (Vorsetuzumab Biosimilar) products
    CD70 (Vorsetuzumab Biosimilar)
    Antibody Type
    Recombinant Antibody
    Reactivity
    Human
    Host
    • 1
    • 1
    Humanized
    Expression System
    Mammalian cells
    Clonality
    • 2
    Chimeric
    Conjugate
    • 2
    This CD70 (Vorsetuzumab Biosimilar) antibody is un-conjugated
    Application
    Please inquire
    Purpose
    Research Grade Vorsetuzumab Biosimilar Antibody
    Specificity
    CD27 ligand, CD70, TNFSF7, CD27LG, CD27L, CD70 antigen, Tumor necrosis factor ligand superfamily member 7, CD27-L
    Purification
    Protein A or G purified from cell culture supernatant.
    Purity
    >95 % by SDS-PAGE.
    Grade
    Research Grade
    Isotype
    IgG1 kappa
  • Restrictions
    For Research Use only
  • Format
    Liquid
    Concentration
    2.68 mg/mL
    Buffer
    0.01M PBS, pH 7.4.
    Storage
    4 °C,-20 °C,-80 °C
    Storage Comment
    Use a manual defrost freezer and avoid repeated freeze-thaw cycles.Store at +4°C short term (1-2 weeks).Store at -20 °C 12 months. Store at -80°C long term.
    Expiry Date
    12 months
  • Target
    CD70 (Vorsetuzumab Biosimilar)
    Alternative Name
    Vorsetuzumab Biosimilar (CD70 (Vorsetuzumab Biosimilar) Products)
    Target Type
    Biosimilar
    Background
    CD27 ligand, CD70, TNFSF7, CD27LG, CD27L, CD70 antigen, Tumor necrosis factor ligand superfamily member 7, CD27-L
    UniProt
    P32970
    CAS-No
    1165740-62-4
You are here:
Support